Zosano Prices ~15.94M Share Common Stock Offering For Gross Proceeds Of ~$20.8M

FREMONT, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation(NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 15,937,130 shares of its common stock for gross proceeds of approximately$20.8 million, before deducting offering expenses payable by Zosano. The offering is expected to close on or aboutSeptember 3, 2020, subject to the satisfaction of customary closing conditions.